TARO-DOXORUBICIN LIPOSOMAL
TARO PHARMACEUTICALS INC
Quick answers
Is there a shortage of TARO-DOXORUBICIN LIPOSOMAL in Canada?
No. There is no current shortage of TARO-DOXORUBICIN LIPOSOMAL 2MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
CAELYX
BAXTER CORPORATION
PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE FOR INJECTION
DR REDDY'S LABORATORIES LTD
Other Products
ADRIAMYCIN PFS
PFIZER CANADA ULC
DOXORUBICIN HYDROCHLORIDE INJECTION
NOVOPHARM LIMITED
MYOCET
SOPHERION THERAPEUTICS LLC
DOXORUBICIN HYDROCHLORIDE INJECTION, USP
STRIDES PHARMA CANADA INC
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02493020
Strength
2MG
Dosage Form
Suspension
Route
Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TARO PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2% · DIN 02247560
DIN 02315033
DIN 02230251
DIN 02304457
0.05% · DIN 00716618
0.1% · DIN 00716626
0.1% · DIN 00716634
0.05% · DIN 00716642
0.1% · DIN 00716650
1% · DIN 00812382
2% · DIN 00812374
1% · DIN 00812366